Processing

Please wait...

Settings

Settings

Goto Application

1. WO2007076024 - MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1β, INTERLEUKIN-6, TNF-α, HLE, AND iNOS

Publication Number WO/2007/076024
Publication Date 05.07.2007
International Application No. PCT/US2006/049051
International Filing Date 21.12.2006
Chapter 2 Demand Filed 20.11.2007
IPC
A61K 36/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A01N 65/00 2006.01
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
65Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
CPC
A61K 36/746
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
74Rubiaceae (Madder family)
746Morinda
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applicants
  • TAHITIAN NONI INTERNATIONAL, INC. [US]/[US] (AllExceptUS)
  • ZHOU, Bing-nan [CN]/[CN] (UsOnly)
  • JENSEN, Jarakae [US]/[US] (UsOnly)
  • ASAY, Kim [US]/[US] (UsOnly)
  • WEST, Brett [US]/[US] (UsOnly)
  • KREUTER, Matthias-heinrich [CH]/[CH] (UsOnly)
  • RAWSON, Brad [US]/[US] (UsOnly)
  • PALU, Afa, Kehaati [TO]/[TO] (UsOnly)
Inventors
  • ZHOU, Bing-nan
  • JENSEN, Jarakae
  • ASAY, Kim
  • WEST, Brett
  • KREUTER, Matthias-heinrich
  • RAWSON, Brad
  • PALU, Afa, Kehaati
Agents
  • KRIEGER, Michael, F.
Priority Data
11/613,82020.12.2006US
60/752,53421.12.2005US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1β, INTERLEUKIN-6, TNF-α, HLE, AND iNOS
(FR) PREPARATIONS A BASE DE MORINDA CITRIFOLIA POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES PAR INHIBITION DU COX-1, DU COX-2, DE L'INTERLEUKINE-1?, DE L'INTERLEUKINE-6, DU TNF-?, DU HLE, ET DE L'INOS
Abstract
(EN)
Methods and compositions for inhibiting 5 -Lipoxygenase, 15-Lipoxygenase, COX-I, COX-2, Interleukin-l β, Interleukin-6, α, HLE3 and iNOS. Methods and compositions for treating and preventing diseases, including inflammatory diseases and skin cancer. Compositions comprising processed Morinda citrifolia components, some of which include leaf extracts, leaf juice, and/or seed extracts.
(FR)
L'invention porte sur des méthodes et préparations inhibant: la 5 -Lipoxygénase, la 15-Lipoxygénase, le COX-I, le COX-2, l'Interleukine-l ß, l'Interleukine-6 a, le HLE3 et l'iNOS, et sur des méthodes et préparations de traitement et de prévention de maladies dont les maladies inflammatoires et les cancers de la peau. Lesdites préparations comprennent des composants de Morinda citrifolia traité dont certaines comprennent des extraits de feuilles, du jus de feuilles, et/ou des extraits de graines.
Latest bibliographic data on file with the International Bureau